MedPath

Hanwha Chemical

🇧🇪Belgium
Ownership
-
Established
1952-01-01
Employees
-
Market Cap
-
Website
http://www.hanwhacorp.co.kr

Clinical Trials

4

Active:0
Completed:4

Trial Phases

2 Phases

Phase 1:3
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (75.0%)
Phase 3
1 (25.0%)

Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
First Posted Date
2013-07-10
Last Posted Date
2016-07-14
Lead Sponsor
Hanwha Chemical
Target Recruit Count
48
Registration Number
NCT01894412
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
First Posted Date
2011-09-09
Last Posted Date
2013-07-08
Lead Sponsor
Hanwha Chemical
Target Recruit Count
44
Registration Number
NCT01431404
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients

Phase 3
Completed
Conditions
Rheumatoid Arthritis
First Posted Date
2011-01-06
Last Posted Date
2014-07-15
Lead Sponsor
Hanwha Chemical
Target Recruit Count
294
Registration Number
NCT01270997
Locations
🇰🇷

Hospetal for Rheumatic Diseases Hanyang University Medical Center, Seoul, Korea, Republic of

Safety and Pharmacokinetic Characteristics of HD203 in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
First Posted Date
2010-01-08
Last Posted Date
2014-07-15
Lead Sponsor
Hanwha Chemical
Target Recruit Count
42
Registration Number
NCT01044836
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.